Alaunos Therapeutics files Charter Amendment for 1-for-10 reverse stock split effective July 17, 2024

Alaunos Therapeutics, Inc.

Reverse stock split at ratio 1-for-10; effective July 17, 2024 at 5:00 p.m. ET.
Every 10 pre-split shares automatically converted to 1 post-split share; par value unchanged.
Stock continues trading on Nasdaq under symbol TCRT; new CUSIP number 98973P309 effective July 18.
Stockholders approved reverse split at June 6, 2024 annual meeting; board set final ratio on June 26, 2024.
Equiniti Trust Company appointed as exchange agent for the split.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.